Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement

Raimondo Ascione1, Saadeh M Suleiman, Gianni D Angelini

  • 1Bristol Heart Institute, University of Bristol, Bristol, United Kingdom. r.ascionen@bristol.ac.uk

Insights

Adding a warm-blood hot-shot reperfusion to cold-blood cardioplegia did not improve myocardial protection in patients undergoing aortic valve replacement. The technique showed a potential benefit for reducing ischemic stress in the right ventricle.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardioplegia

Background:

  • Cold-blood cardioplegia with warm-blood hot-shot reperfusion may reduce myocardial injury during coronary surgery.
  • Its effectiveness in patients with left ventricular hypertrophy due to aortic stenosis is not well-established.

Purpose of the Study:

  • To evaluate the efficacy of adding a retrograde warm-blood hot-shot to antegrade cold-blood cardioplegia in preventing myocardial injury.
  • To assess myocardial protection in patients with left ventricular hypertrophy undergoing aortic valve replacement.

Main Methods:

  • Prospective randomized trial of 36 patients undergoing aortic valve replacement.
  • Comparison of cold-blood cardioplegia alone versus cold-blood cardioplegia with retrograde hot-shot.
  • Assessment of myocardial adenosine triphosphate and lactate levels, and troponin I release.

Main Results:

  • No significant difference in myocardial adenosine triphosphate or lactate levels post-reperfusion between groups.
  • A trend towards decreased adenosine triphosphate in the cold-blood cardioplegia group, significant in the right ventricle.
  • Elevated troponin I in both groups, not indicative of myocardial infarction.

Conclusions:

  • Terminal retrograde hot-shot reperfusion offers no additional benefit over antegrade cold-blood cardioplegia for myocardial protection in this patient group.
  • A potential benefit for reducing right ventricular ischemic stress was observed.
  • No significant difference in clinical outcomes was noted between the two groups.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...